Citation: Zs. Burgess et Aj. Goudie, CROSS-TOLERANCE TO THE CLOZAPINE DISCRIMINATIVE STIMULUS-INDUCED BY THE NOVEL PUTATIVE ATYPICAL ANTIPSYCHOTIC JL13, British Journal of Pharmacology, 124, 1998, pp. 53-53
Citation: Aj. Goudie et A. Taylor, OLANZAPINE GENERALIZATION TO THE CLOZAPINE DISCRIMINATIVE STIMULUS ISDETERMINED BY CLOZAPINE TRAINING DOSE, British Journal of Pharmacology, 124, 1998, pp. 54-54
Citation: Ja. Smith et Aj. Goudie, LACK OF EVIDENCE FOR THE ROLE OF D4 RECEPTORS IN THE BEHAVIORAL-EFFECTS OF CLOZAPINE IN RATS, British Journal of Pharmacology, 124, 1998, pp. 55-55
Citation: Lh. Brauer et al., DOPAMINE LIGANDS AND THE STIMULUS EFFECTS OF AMPHETAMINE - ANIMAL-MODELS VERSUS HUMAN LABORATORY DATA, Psychopharmacology, 130(1), 1997, pp. 2-13
Citation: Aj. Goudie et al., CLOZAPINE DRUG DISCRIMINATION IN RATS - A PHARMACOLOGICALLY SPECIFIC STIMULUS, British Journal of Pharmacology, 120, 1997, pp. 241-241
Citation: A. Taylor et al., CLOZAPINE DRUG DISCRIMINATION IN RATS - EFFECTS OF ATYPICAL NEUROLEPTICS, British Journal of Pharmacology, 120, 1997, pp. 242-242
Citation: Aj. Goudie et Mj. Leathley, LACK OF EFFECT OF THE CCK-B ANTAGONIST CI-988 ON BENZODIAZEPINE WITHDRAWAL-INDUCED WEIGHT-LOSS, British Journal of Pharmacology, 119, 1996, pp. 215-215
Citation: Aj. Goudie et Mj. Leathley, EFFECTS OF THE CCKB ANTAGONIST L-365,260 ON BENZODIAZEPINE WITHDRAWAL-INDUCED HYPOPHAGIA IN RATS, Psychopharmacology, 118(1), 1995, pp. 57-64
Citation: Aj. Goudie et al., COMPARATIVE DISCRIMINATIVE STIMULUS PROPERTIES OF CHLORDIAZEPOXIDE AND THE PUTATIVE ANXIOLYTIC AHR-14042 IN RATS, British Journal of Pharmacology, 116, 1995, pp. 127-127
Citation: Aj. Goudie et al., ANALYSTS OF THE MODE OF ACTION IN RATS OF THE PUTATIVE ANXIOLYTIC AHR-14042 IN AN IN-VIVO DRUG DISCRIMINATION ASSAY, British Journal of Pharmacology, 116, 1995, pp. 128-128
Citation: Aj. Goudie et al., EFFECT OF THE 5-HT3 ANTAGONIST ONDANSETRON ON CHLORDIAZEPOXIDE WITHDRAWAL HYPERTHERMIA, British Journal of Pharmacology, 114, 1995, pp. 379-379
Citation: Aj. Goudie et al., ASSESSMENT OF THE BENZODIAZEPINE-LIKE DEPENDENCE POTENTIAL IN RATS OFTHE PUTATIVE 5-HT1A AGONIST ANXIOLYTIC S-20499, Behavioural pharmacology, 5(2), 1994, pp. 131-140
Citation: Aj. Goudie et Mj. Leathley, ASSESSMENT OF THE DEPENDENCE POTENTIAL OF THE POTENT HIGH-EFFICACY 5-HT1A AGONIST S-14506 IN RATS, J PSYCHOPH, 8(4), 1994, pp. 213-221
Citation: Aj. Goudie et Mj. Leathley, ASSESSMENT OF THE DEPENDENCE POTENTIAL OF THE HIGH-EFFICACY 5-HT1A AGONIST, S-14506, IN RATS, British Journal of Pharmacology, 112, 1994, pp. 210000111-210000111
Citation: Aj. Goudie, SOME FUTURE-RESEARCH DIRECTIONS - COMMENTARY ON TOLERANCE AND SENSITIZATION TO THE BEHAVIORAL-EFFECTS OF DRUGS, Behavioural pharmacology, 4(4), 1993, pp. 313-314
Citation: Aj. Goudie et Mj. Leathley, ACTIONS OF RITANSERIN, A 5-HT2 1C ANTAGONIST, IN BENZODIAZEPINE-DEPENDENT RATS/, Behavioural pharmacology, 4(3), 1993, pp. 247-255
Citation: M. Thabit et Aj. Goudie, THE DOPAMINE UPTAKE INHIBITOR GBR-12909 INDUCES CROSS-TOLERANCE TO RATE-SUPPRESSANT ACTIONS OF COCAINE IN RATS, British Journal of Pharmacology, 110, 1993, pp. 160000091-160000091